SHIREEN ALWANI: Open Payments
NPI 1982870291 · PARAMOUNT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 29 payments from 13 companies in 2025. Trend: 2023 $243 · 2024 $651 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $210 |
| Lilly USA, LLC | 5 | $117 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $37 |
| Exact Sciences Corporation | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $22 |
Products named: Kerendia, MOUNJARO, Wegovy, The Cologuard Plus Collection Kit, GEMTESA, OTEZLA, AIRSUPRA, APTIMA.
Industry payments across CA — which companies pay providers there.
